MARKET WIRE NEWS

Biodesix, Inc. (BDSX) Q4 2024 Earnings Call Transcript

Source: SeekingAlpha

2025-03-03 20:06:21 ET

Biodesix, Inc. (BDSX)

Q4 2024 Earnings Conference Call

March 3, 2025, 4:30 PM ET

Company Participants

Chris Brinzey - Investor Relations

Scott Hutton - Chief Executive Officer

Robin Harper Cowie - Chief Financial Officer

Conference Call Participants

Andrew Brackmann - William Blair

Kyle Mikson - Canaccord

Dan Brennan - TD Cowen

Thomas Flaten - Lake Street Capital Markets

William Bonello - Craig-Hallum

Sung Ji Nam - Scotiabank

Presentation

Operator

Good day and thank you for standing by. Welcome to the Biodesix’s Q4 2024 Earnings Conference Call. At this time, all participants are in a listen-only mode. After the speaker’s presentation, there’ll be a question-and-answer session. [Operator Instructions]

Please be advised that today’s conference is being recorded. I would now like to turn the conference over to Chris Brinzey, Biodesix’s Investor Relations. Please go ahead.

Chris Brinzey

Thank you, Operator, and good afternoon, everyone. Today, Biodesix’s released results from the fourth quarter and full year of 2024. Leading the call today will be Scott Hutton, Chief Executive Officer. He is joined by Robin Harper Cowie, Chief Financial Officer. An audio recording of today’s call and the press release announcement with the quarterly results can be found in the Investor Relations section of the company’s website at biodesix.com.

As today’s call includes forward-looking statements, we encourage you to review the statements contained in today’s press release and the risks and uncertainties described in our SEC filing, which identify certain factors that may cause the company’s actual events, performance and results to differ materially from those contained in the forward-looking statements made on today’s webcast.

In addition, we will discuss non-GAAP financial measures on this call. Descriptions of these non-GAAP financial measures and reconciliations of GAAP to non-GAAP financial measures are included in today’s press release....

Read the full article on Seeking Alpha

For further details see:

Biodesix, Inc. (BDSX) Q4 2024 Earnings Call Transcript
Biodesix Inc.

NASDAQ: BDSX

BDSX Trading

1.26% G/L:

$19.28 Last:

37,157 Volume:

$19.30 Open:

mwn-alerts Ad 300

BDSX Latest News

February 26, 2026 07:14:05 pm
Biodesix (BDSX) Q4 2025 Earnings Call Transcript

BDSX Stock Data

$83,296,022
3,850,552
19.65%
10
N/A
Medical Diagnostics & Screening
Healthcare
US
Louisville

Subscribe to Our Newsletter

Link Market Wire News to Your X Account

Download The Market Wire News App